List of Tables
Table 1. Recombinant Glycosylated Proteins Biosimilar Market Trends
Table 2. Recombinant Glycosylated Proteins Biosimilar Market Drivers & Opportunity
Table 3. Recombinant Glycosylated Proteins Biosimilar Market Challenges
Table 4. Recombinant Glycosylated Proteins Biosimilar Market Restraints
Table 5. Global Recombinant Glycosylated Proteins Biosimilar Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Recombinant Glycosylated Proteins Biosimilar Revenue Market Share by Company (2019-2024)
Table 7. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Company (2019-2024) & (K Units)
Table 8. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume Market Share by Company (2019-2024)
Table 9. Global Market Recombinant Glycosylated Proteins Biosimilar Price by Company (2019-2024) & (US$/Unit)
Table 10. Key Manufacturers Recombinant Glycosylated Proteins Biosimilar Manufacturing Base Distribution and Headquarters
Table 11. Key Manufacturers Recombinant Glycosylated Proteins Biosimilar Product Type
Table 12. Key Manufacturers Time to Begin Mass Production of Recombinant Glycosylated Proteins Biosimilar
Table 13. Global Recombinant Glycosylated Proteins Biosimilar Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Recombinant Glycosylated Proteins Biosimilar as of 2023)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 17. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (2019-2024) & (US$ Million)
Table 18. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (2025-2030) & (US$ Million)
Table 19. Global Recombinant Glycosylated Proteins Biosimilar Sales Market Share in Value by Type (2019-2024) & (%)
Table 20. Global Recombinant Glycosylated Proteins Biosimilar Sales Market Share in Value by Type (2025-2030) & (%)
Table 21. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
Table 22. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Type (2019-2024) & (K Units)
Table 23. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Type (2025-2030) & (K Units)
Table 24. Global Recombinant Glycosylated Proteins Biosimilar Sales Market Share in Volume by Type (2019-2024) & (%)
Table 25. Global Recombinant Glycosylated Proteins Biosimilar Sales Market Share in Volume by Type (2025-2030) & (%)
Table 26. Global Recombinant Glycosylated Proteins Biosimilar Price by Type (2019-2024) & (US$/Unit)
Table 27. Global Recombinant Glycosylated Proteins Biosimilar Price by Type (2025-2030) & (US$/Unit)
Table 28. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 29. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (2019-2024) & (US$ Million)
Table 30. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (2025-2030) & (US$ Million)
Table 31. Global Recombinant Glycosylated Proteins Biosimilar Sales Market Share in Value by Application (2019-2024) & (%)
Table 32. Global Recombinant Glycosylated Proteins Biosimilar Sales Market Share in Value by Application (2025-2030) & (%)
Table 33. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
Table 34. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Application (2019-2024) & (K Units)
Table 35. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Application (2025-2030) & (K Units)
Table 36. Global Recombinant Glycosylated Proteins Biosimilar Sales Market Share in Volume by Application (2019-2024) & (%)
Table 37. Global Recombinant Glycosylated Proteins Biosimilar Sales Market Share in Volume by Application (2025-2030) & (%)
Table 38. Global Recombinant Glycosylated Proteins Biosimilar Price by Application (2019-2024) & (US$/Unit)
Table 39. Global Recombinant Glycosylated Proteins Biosimilar Price by Application (2025-2030) & (US$/Unit)
Table 40. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 41. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Region (2019-2024) & (US$ Million)
Table 42. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Region (2025-2030) & (US$ Million)
Table 43. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Region (2019-2024) & (%)
Table 44. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Region (2025-2030) & (%)
Table 45. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
Table 46. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Region (2019-2024) & (K Units)
Table 47. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Region (2025-2030) & (K Units)
Table 48. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Region (2019-2024) & (%)
Table 49. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Region (2025-2030) & (%)
Table 50. Global Recombinant Glycosylated Proteins Biosimilar Average Price by Region (2019-2024) & (US$/Unit)
Table 51. Global Recombinant Glycosylated Proteins Biosimilar Average Price by Region (2025-2030) & (US$/Unit)
Table 52. Key Countries/Regions Recombinant Glycosylated Proteins Biosimilar Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 53. Key Countries/Regions Recombinant Glycosylated Proteins Biosimilar Sales Value, (2019-2024) & (US$ Million)
Table 54. Key Countries/Regions Recombinant Glycosylated Proteins Biosimilar Sales Value, (2025-2030) & (US$ Million)
Table 55. Key Countries/Regions Recombinant Glycosylated Proteins Biosimilar Sales Volume, (2019-2024) & (K Units)
Table 56. Key Countries/Regions Recombinant Glycosylated Proteins Biosimilar Sales Volume, (2025-2030) & (K Units)
Table 57. Pfizer, Inc. Company Information
Table 58. Pfizer, Inc. Introduction and Business Overview
Table 59. Pfizer, Inc. Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 60. Pfizer, Inc. Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 61. Pfizer, Inc. Recent Development
Table 62. Intas Pharmaceuticals Ltd. Company Information
Table 63. Intas Pharmaceuticals Ltd. Introduction and Business Overview
Table 64. Intas Pharmaceuticals Ltd. Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 65. Intas Pharmaceuticals Ltd. Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 66. Intas Pharmaceuticals Ltd. Recent Development
Table 67. Biocon Company Information
Table 68. Biocon Introduction and Business Overview
Table 69. Biocon Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 70. Biocon Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 71. Biocon Recent Development
Table 72. Dr. Reddy’s Laboratories Ltd. Company Information
Table 73. Dr. Reddy’s Laboratories Ltd. Introduction and Business Overview
Table 74. Dr. Reddy’s Laboratories Ltd. Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 75. Dr. Reddy’s Laboratories Ltd. Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 76. Dr. Reddy’s Laboratories Ltd. Recent Development
Table 77. Teva Pharmaceutical Industries Ltd. Company Information
Table 78. Teva Pharmaceutical Industries Ltd. Introduction and Business Overview
Table 79. Teva Pharmaceutical Industries Ltd. Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 80. Teva Pharmaceutical Industries Ltd. Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 81. Teva Pharmaceutical Industries Ltd. Recent Development
Table 82. Sandoz International GmbH (A Novartis Division) Company Information
Table 83. Sandoz International GmbH (A Novartis Division) Introduction and Business Overview
Table 84. Sandoz International GmbH (A Novartis Division) Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 85. Sandoz International GmbH (A Novartis Division) Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 86. Sandoz International GmbH (A Novartis Division) Recent Development
Table 87. Celltrion Inc. Company Information
Table 88. Celltrion Inc. Introduction and Business Overview
Table 89. Celltrion Inc. Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 90. Celltrion Inc. Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 91. Celltrion Inc. Recent Development
Table 92. Amgen, Inc. Company Information
Table 93. Amgen, Inc. Introduction and Business Overview
Table 94. Amgen, Inc. Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 95. Amgen, Inc. Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 96. Amgen, Inc. Recent Development
Table 97. STADA Arzneimittel AG Company Information
Table 98. STADA Arzneimittel AG Introduction and Business Overview
Table 99. STADA Arzneimittel AG Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 100. STADA Arzneimittel AG Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 101. STADA Arzneimittel AG Recent Development
Table 102. Apotex Inc. Company Information
Table 103. Apotex Inc. Introduction and Business Overview
Table 104. Apotex Inc. Recombinant Glycosylated Proteins Biosimilar Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
Table 105. Apotex Inc. Recombinant Glycosylated Proteins Biosimilar Product Offerings
Table 106. Apotex Inc. Recent Development
Table 107. Key Raw Materials Lists
Table 108. Raw Materials Key Suppliers Lists
Table 109. Recombinant Glycosylated Proteins Biosimilar Downstream Customers
Table 110. Recombinant Glycosylated Proteins Biosimilar Distributors List
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
List of Figures
Figure 1. Recombinant Glycosylated Proteins Biosimilar Product Picture
Figure 2. Global Recombinant Glycosylated Proteins Biosimilar Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Recombinant Glycosylated Proteins Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 4. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume (2019-2030) & (K Units)
Figure 5. Global Recombinant Glycosylated Proteins Biosimilar Sales Price (2019-2030) & (US$/Unit)
Figure 6. Recombinant Glycosylated Proteins Biosimilar Report Years Considered
Figure 7. Global Recombinant Glycosylated Proteins Biosimilar Players Revenue Ranking (2023) & (US$ Million)
Figure 8. Global Recombinant Glycosylated Proteins Biosimilar Players Sales Volume Ranking (2023) & (K Units)
Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Recombinant Glycosylated Proteins Biosimilar Revenue in 2023
Figure 10. Recombinant Glycosylated Proteins Biosimilar Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 11. Monoclonal Antibodies Picture
Figure 12. Erythropoietin Picture
Figure 13. Others Picture
Figure 14. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 15. Global Recombinant Glycosylated Proteins Biosimilar Sales Value Market Share by Type, 2023 & 2030
Figure 16. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
Figure 17. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume Market Share by Type, 2023 & 2030
Figure 18. Global Recombinant Glycosylated Proteins Biosimilar Price by Type (2019-2030) & (US$/Unit)
Figure 19. Product Picture of Chronic Diseases
Figure 20. Product Picture of Oncology
Figure 21. Product Picture of Autoimmune Diseases
Figure 22. Product Picture of Infectious Diseases
Figure 23. Product Picture of Blood Disorders
Figure 24. Product Picture of Growth Hormone Deficiency
Figure 25. Product Picture of Others
Figure 26. Global Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 27. Global Recombinant Glycosylated Proteins Biosimilar Sales Value Market Share by Application, 2023 & 2030
Figure 28. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
Figure 29. Global Recombinant Glycosylated Proteins Biosimilar Sales Volume Market Share by Application, 2023 & 2030
Figure 30. Global Recombinant Glycosylated Proteins Biosimilar Price by Application (2019-2030) & (US$/Unit)
Figure 31. North America Recombinant Glycosylated Proteins Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 32. North America Recombinant Glycosylated Proteins Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 33. Europe Recombinant Glycosylated Proteins Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 34. Europe Recombinant Glycosylated Proteins Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 35. Asia Pacific Recombinant Glycosylated Proteins Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 36. Asia Pacific Recombinant Glycosylated Proteins Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 37. South America Recombinant Glycosylated Proteins Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 38. South America Recombinant Glycosylated Proteins Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 39. Middle East & Africa Recombinant Glycosylated Proteins Biosimilar Sales Value (2019-2030) & (US$ Million)
Figure 40. Middle East & Africa Recombinant Glycosylated Proteins Biosimilar Sales Value by Country (%), 2023 VS 2030
Figure 41. Key Countries/Regions Recombinant Glycosylated Proteins Biosimilar Sales Value (%), (2019-2030)
Figure 42. Key Countries/Regions Recombinant Glycosylated Proteins Biosimilar Sales Volume (%), (2019-2030)
Figure 43. United States Recombinant Glycosylated Proteins Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 44. United States Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 45. United States Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 46. Europe Recombinant Glycosylated Proteins Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 47. Europe Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 48. Europe Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 49. China Recombinant Glycosylated Proteins Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 50. China Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 51. China Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 52. Japan Recombinant Glycosylated Proteins Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 53. Japan Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 54. Japan Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 55. South Korea Recombinant Glycosylated Proteins Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 56. South Korea Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 57. South Korea Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 58. Southeast Asia Recombinant Glycosylated Proteins Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 59. Southeast Asia Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 60. Southeast Asia Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 61. India Recombinant Glycosylated Proteins Biosimilar Sales Value, (2019-2030) & (US$ Million)
Figure 62. India Recombinant Glycosylated Proteins Biosimilar Sales Value by Type (%), 2023 VS 2030
Figure 63. India Recombinant Glycosylated Proteins Biosimilar Sales Value by Application (%), 2023 VS 2030
Figure 64. Recombinant Glycosylated Proteins Biosimilar Industrial Chain
Figure 65. Recombinant Glycosylated Proteins Biosimilar Manufacturing Cost Structure
Figure 66. Channels of Distribution (Direct Sales, and Distribution)
Figure 67. Bottom-up and Top-down Approaches for This Report
Figure 68. Data Triangulation
Figure 69. Key Executives Interviewed
